United States 119th Congress Status: In Committee Bipartisan · 4 D · 3 R cosponsors

S 233 — Restoring Confidence in the World Anti-Doping Agency Act of 2025

Last action — Placed on Senate Legislative Calendar under General Orders. Calendar No. 340.

  1. ✓
    Introduced
  2. 2
    In Committee
  3. 3
    Passed Senate
  4. 4
    Passed House
  5. 5
    To Executive
  6. 6
    Enacted

This bill is in committee in the Senate. Introduced January 23, 2025. It must pass committee before a floor vote.

Next likely step: a committee vote, then a floor vote in the Senate.

Odds of enactment

Low chance

Based on the sponsor, cosponsors, and committee posture, this bill has a low chance of becoming law.

Upgrade to see the exact probability and what's driving it.

A statistical estimate from our own model of past outcomes — an insight, not a guarantee. Policymaking is volatile.

Prognosis

Advancing 42% · moderate confidence

  • In Committee

    Current position in the legislative process.

  • 7 sponsors

    1 primary, 6 co-sponsors signed on.

  • Bipartisan support

    Sponsored across 2 parties (4 D · 3 R) — cross-party backing.

Based on stage, sponsorship breadth, committee status, recorded votes, and cross-state momentum — a description of the observable signals, not a prediction.

Summary

Restoring Confidence in the World Anti-Doping Agency Act of 2025This bill requires the Office of National Drug Control Policy (ONDCP) to annually evaluate the governance and procedures of the World Anti-Doping Agency (WADA).Specifically, the ONDCP, in consultation with the United States Anti-Doping Agency, the United States Olympic and Paralympic Committee, the Athletes' Advisory Council (Team USA AC), must determine whether WADAhas a credible and independent governance model that provides for fair representation of the United States; fully implements or has implemented governance reforms to ensure independent governance; andhas fair processes and procedures for selecting independent athletes for decision-making roles on the WADA Executive Committee, the WADA Foundation Board, and relevant expert advisory groups, standing committees, permanent special committees, and working groups of WADA.If the ONDCP determines WADA has not met these criteria, the ONDCP must use all available tools and efforts to bring WADA into compliance with them.Further, upon such a determination, the ONDCP may withhold up to the full amount of the United States' membership dues to WADA.

Bill Text

What changed in the latest version

274 added · 119 removed

Plain-language change summary

The amendment to the bill updates the definition of the "United States Olympic and Paralympic Committee" in the text, specifically correcting the legal citation for consistency. It also introduces new definitions and reorders existing paragraphs for clarity. These changes provide clearer terminology and structure, which helps ensure that the bill is precise and easily understood.

→
Previous
Latest
233 Introduced in Senate (IS)] <DOC> 119th CONGRESS 1st Session S.
233 Reported in Senate (RS)] <DOC> Calendar No.
233 To amend the Office of National Drug Control Policy Reauthorization Act of 2006 to modify the authority of the Office of National Drug Control Policy with respect to the World Anti-Doping Agency, and for other purposes.
340 119th CONGRESS 2d Session S.
233 [Report No.
119-111] To amend the Office of National Drug Control Policy Reauthorization Act of 2006 to modify the authority of the Office of National Drug Control Policy with respect to the World Anti-Doping Agency, and for other purposes.
Blumenthal, and Mr.
Blumenthal, Mr.
Wicker) introduced the following bill;
Wicker, Ms.
which was read twice and referred to the Committee on Commerce, Science, and Transportation _______________________________________________________________________ A BILL To amend the Office of National Drug Control Policy Reauthorization Act of 2006 to modify the authority of the Office of National Drug Control Policy with respect to the World Anti-Doping Agency, and for other purposes.
Blunt Rochester, and Mr.
Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled, SECTION 1.
Lujan) introduced the following bill;
which was read twice and referred to the Committee on Commerce, Science, and Transportation February 23, 2026 Reported by Mr.
Cruz, with an amendment [Strike out all after the enacting clause and insert the part printed in italic] _______________________________________________________________________ A BILL To amend the Office of National Drug Control Policy Reauthorization Act of 2006 to modify the authority of the Office of National Drug Control Policy with respect to the World Anti-Doping Agency, and for other purposes.
Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled, <DELETED>SECTION 1.
SHORT TITLE.</DELETED> <DELETED> This Act may be cited as the ``Restoring Confidence in the World Anti-Doping Agency Act of 2025''.</DELETED> <DELETED>SEC.
2.
AUTHORITY OF NATIONAL DRUG CONTROL POLICY WITH RESPECT TO THE WORLD ANTI-DOPING AGENCY.</DELETED> <DELETED> Section 701 of the Office of National Drug Control Policy Reauthorization Act of 2006 (21 U.S.C.
2001) is amended--</DELETED> <DELETED> (1) in subsection (a)--</DELETED> <DELETED> (A) by amending paragraph (1) to read as follows:</DELETED> <DELETED> ``(1) United states olympic and paralympic committee.--The term `United States Olympic and Paralympic Committee' means the organization established by chapter 2205 of title 36, United States Code.'';</DELETED> <DELETED> (B) in paragraph (3), by striking ``(36 U.S.C.
22501(b)(1))'' and inserting ``(36 U.S.C.
220501(b)(1))'';</DELETED> <DELETED> (C) by redesignating paragraphs (1) and (3) as paragraphs (4) and (1), respectively, and moving the paragraphs so as to appear in numeric order;
and</DELETED> <DELETED> (D) by inserting after paragraph (2) the following:</DELETED> <DELETED> ``(3) Independent athlete.--The term `independent athlete' means an Olympic or Paralympic athlete who does not serve, in any capacity--</DELETED> <DELETED> ``(A) on the International Olympic Committee;</DELETED> <DELETED> ``(B) on the International Paralympic Committee;</DELETED> <DELETED> ``(C) at an international sports federation recognized by the International Olympic Committee or the International Paralympic Committee;</DELETED> <DELETED> ``(D) on the United States Olympic and Paralympic Committee;
or</DELETED> <DELETED> ``(E) at the World Anti-Doping Agency.'';</DELETED> <DELETED> (2) in subsection (b)--</DELETED> <DELETED> (A) by striking ``United States Olympic Committee'' each place it appears and inserting ``United States Olympic and Paralympic Committee'';</DELETED> <DELETED> (B) in paragraph (5), by striking the period at the end and inserting ``;
and'';
and</DELETED> <DELETED> (C) by adding at the end the following:</DELETED> <DELETED> ``(6) carry out responsibilities with respect to the World Anti-Doping Agency, as described in subsection (d).'';
and</DELETED> <DELETED> (3) by adding at the end the following:</DELETED> <DELETED> ``(d) Authority With Respect to the World Anti-Doping Agency.--</DELETED> <DELETED> ``(1) In general.--The Office of National Drug Control Policy, in consultation with the United States Anti- Doping Agency, the United States Olympic and Paralympic Committee, and the Team USA Athletes' Commission, shall-- </DELETED> <DELETED> ``(A) use all available tools to ensure that--</DELETED> <DELETED> ``(i) the World Anti-Doping Agency has a credible and independent governance model that provides for fair representation of the United States;</DELETED> <DELETED> ``(ii) the World Anti-Doping Agency fully implements all governance reforms, including a proper conflict-of-interest policy for all members of the Executive Committee, the Foundation Board, and all relevant expert advisory groups, standing committees, permanent special committees, and working groups of the World Anti-Doping Agency;
and</DELETED> <DELETED> ``(iii) independent athletes from the United States and other democratic countries, or representatives of such athletes, have decision-making roles on the Executive Committee and the Foundation Board, and in all relevant expert advisory groups, standing committees, permanent special committees, and working groups, of the World Anti-Doping Agency;</DELETED> <DELETED> ``(B) demonstrate leadership within the global community;</DELETED> <DELETED> ``(C) have strict standards that work toward countering doping in every form, including by countering systemic fraud through doping involving-- </DELETED> <DELETED> ``(i) governmental law enforcement, intelligence, or anti-doping institutions;</DELETED> <DELETED> ``(ii) sporting organizations;
or</DELETED> <DELETED> ``(iii) athlete support personnel;
and</DELETED> <DELETED> ``(D) work collaboratively with democratic countries.</DELETED> <DELETED> ``(2) Determination.--</DELETED> <DELETED> ``(A) In general.--Not later than 90 days after the date of the enactment of this subsection, the Office of National Drug Control Policy, in consultation with the United States Anti-Doping Agency, the United States Olympic and Paralympic Committee, and the Team USA Athletes' Commission, shall make a determination as to whether the World Anti-Doping Agency--</DELETED> <DELETED> ``(i) has a credible and independent governance model that provides for fair representation of the United States;</DELETED> <DELETED> ``(ii) fully implements all governance reforms, including a proper conflict-of-interest policy described in paragraph (1)(A)(ii);
and</DELETED> <DELETED> ``(iii) allows independent athletes from the United States and other democratic countries, or representatives of such athletes, to have decision-making roles on the Executive Committee and the Foundation Board, and in all relevant expert advisory groups, standing committees, permanent special committees, and working groups, of the World Anti-Doping Agency.</DELETED> <DELETED> ``(B) Accountability.--In the case of a determination under subparagraph (A) that the World Anti-Doping Agency does not have such a governance model, has not fully implemented such governance reforms, or has not allowed decision-making roles described in clause (iii) of that subparagraph, the Office of National Drug Control Policy, in consultation with the United States Anti-Doping Agency, the United States Olympic and Paralympic Committee, and the Team USA Athletes' Commission, shall--</DELETED> <DELETED> ``(i) use all available tools to ensure that the United States has fair representation in the World Anti-Doping Agency, including--</DELETED> <DELETED> ``(I) on the Executive Committee;</DELETED> <DELETED> ``(II) on the Foundation Board;
and</DELETED> <DELETED> ``(III) in all relevant expert advisory groups, standing committees, permanent special committees, and working groups of the World Anti-Doping Agency;
and</DELETED> <DELETED> ``(ii) not later than 180 days after the date on which the determination under subparagraph (A) is made, issue a report that describes the barriers to participation and fair representation of the United States on the Executive Committee, the Foundation Board, and all relevant expert advisory groups, standing committees, permanent special committees, and working groups of the World Anti-Doping Agency.</DELETED> <DELETED> ``(3) Voluntary nonpayment of dues.--</DELETED> <DELETED> ``(A) In general.--In the case of a determination under paragraph (2)(A) that the World Anti-Doping Agency does not have a governance model that provides for fair representation of the United States, has not fully implemented governance reforms, or has not allowed decision-making roles described in clause (iii) of that subparagraph, the Office of National Drug Control Policy, in consultation with the appropriate committees of Congress, may voluntarily withhold up to the full amount of membership dues to the World Anti-Doping Agency.</DELETED> <DELETED> ``(B) Appropriate committees of congress defined.--In this paragraph, the term `appropriate committees of Congress' means--</DELETED> <DELETED> ``(i) the Subcommittee on Consumer Protection, Product Safety, and Data Security of the Committee on Commerce, Science, and Transportation of the Senate (or a successor subcommittee);</DELETED> <DELETED> ``(ii) the Subcommittee on Financial Services and General Government of the Committee on Appropriations of the Senate (or a successor subcommittee);</DELETED> <DELETED> ``(iii) the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce of the House of Representatives (or a successor subcommittee);
and</DELETED> <DELETED> ``(iv) the Subcommittee on Financial Services and General Government of the Committee on Appropriations of the House of Representatives (or a successor subcommittee).</DELETED> <DELETED> ``(4) Spending plan.--Not later than 30 days before the Office of National Drug Control Policy obligates funds to the World Anti-Doping Agency, the Office of National Drug Control Policy shall submit to the Committee on Appropriations of the Senate and the Committee on Appropriations of the House of Representatives a spending plan and explanation of proposed uses of such funds.''.</DELETED> SECTION 1.
2001) is amended-- (1) in subsection (a)-- (A) by amending paragraph (1) to read as follows:
2001) is amended-- (1) by striking subsection (a) and inserting the following:
``(1) United states olympic and paralympic committee.--The term `United States Olympic and Paralympic Committee' means the organization established by chapter 2205 of title 36, United States Code.'';
``(a) Definitions.--In this subchapter:
(B) in paragraph (3), by striking ``(36 U.S.C.
``(1) Amateur athlete.--The term `amateur athlete' has the meaning given that term in section 220501(b)(1) of title 36, United States Code.
22501(b)(1))'' and inserting ``(36 U.S.C.
``(2) Amateur athletic competition.--The term `amateur athletic competition' has the meaning given that term in section 220501(b)(2) of title 36, United States Code.
220501(b)(1))'';
``(3) Independent athlete.--The term `independent athlete' means a current or former amateur athlete who does not serve, in any capacity-- ``(A) on the International Olympic Committee;
(C) by redesignating paragraphs (1) and (3) as paragraphs (4) and (1), respectively, and moving the paragraphs so as to appear in numeric order;
and (D) by inserting after paragraph (2) the following:
``(3) Independent athlete.--The term `independent athlete' means an Olympic or Paralympic athlete who does not serve, in any capacity-- ``(A) on the International Olympic Committee;
or ``(E) at the World Anti-Doping Agency.'';
``(E) at a national governing body (as defined in section 220501(b)(9) of title 36, United States Code);
(2) in subsection (b)-- (A) by striking ``United States Olympic Committee'' each place it appears and inserting ``United States Olympic and Paralympic Committee'';
or ``(F) at the World Anti-Doping Agency.
(B) in paragraph (5), by striking the period at the end and inserting ``;
``(4) United states olympic and paralympic committee.--The term `United States Olympic and Paralympic Committee' means the organization established by chapter 2205 of title 36, United States Code.'';
Show all 65 changed rows (25 more)
Previous
Latest
and'';
(2) in subsection (b), by striking ``United States Olympic Committee'' each place it appears and inserting ``United States Olympic and Paralympic Committee'';
and (C) by adding at the end the following:
``(6) carry out responsibilities with respect to the World Anti-Doping Agency, as described in subsection (d).'';
``(d) Authority With Respect to the World Anti-Doping Agency.-- ``(1) In general.--The Office of National Drug Control Policy, in consultation with the United States Anti-Doping Agency, the United States Olympic and Paralympic Committee, and the Team USA Athletes' Commission, shall-- ``(A) use all available tools to ensure that-- ``(i) the World Anti-Doping Agency has a credible and independent governance model that provides for fair representation of the United States;
``(d) Authority With Respect to the World Anti-Doping Agency.-- ``(1) Annual determination.--Not later than 180 days after the date of the enactment of this subsection, and annually thereafter, the Office of National Drug Control Policy, in consultation with the United States Anti-Doping Agency, the United States Olympic and Paralympic Committee, and the Athletes' Advisory Council (established and maintained under section 220504(b)(2)(A) of title 36, United States Code) shall make a determination as to whether the World Anti-Doping Agency-- ``(A) has a credible and independent governance model that provides for fair representation of the United States;
``(ii) the World Anti-Doping Agency fully implements all governance reforms, including a proper conflict-of-interest policy for all members of the Executive Committee, the Foundation Board, and all relevant expert advisory groups, standing committees, permanent special committees, and working groups of the World Anti-Doping Agency;
``(B) fully implements or has implemented governance reforms to ensure independent governance;
and ``(iii) independent athletes from the United States and other democratic countries, or representatives of such athletes, have decision-making roles on the Executive Committee and the Foundation Board, and in all relevant expert advisory groups, standing committees, permanent special committees, and working groups, of the World Anti-Doping Agency;
and ``(C) has fair processes and procedures to select independent athletes, including athletes from the United States and other democratic countries, or representatives of such athletes, for decision-making roles on the Executive Committee and the Foundation Board, and in all relevant expert advisory groups, standing committees, permanent special committees, and working groups of the World Anti-Doping Agency.
``(B) demonstrate leadership within the global community;
``(2) Accountability.--In the case of a determination under paragraph (1) that the World Anti-Doping Agency has not met the criteria set forth in subparagraphs (A), (B), or (C) of that paragraph, the Office of National Drug Control Policy, in consultation with the United States Anti-Doping Agency, the United States Olympic and Paralympic Committee, and the Athletes' Advisory Council (established and maintained under section 220504(b)(2)(A) of title 36, United States Code), shall use all available tools and best efforts to bring the World Anti-Doping Agency into compliance with the criteria set forth in that paragraph.
``(C) have strict standards that work toward countering doping in every form, including by countering systemic fraud through doping involving-- ``(i) governmental law enforcement, intelligence, or anti-doping institutions;
``(3) Report.--In the case of a determination under paragraph (1) that the World Anti-Doping Agency has not met the criteria set forth in subparagraphs (A), (B), or (C) of that paragraph, not later than 180 days after the date on which that determination is made, the Office of National Drug Control Policy, in consultation with the United States Anti-Doping Agency, the United States Olympic and Paralympic Committee, and the Athletes' Advisory Council (established and maintained under section 220504(b)(2)(A) of title 36, United States Code) shall submit to the appropriate committees of Congress a report that describes the barriers to participation and fair representation of the United States on the Executive Committee, the Foundation Board, and all relevant expert advisory groups, standing committees, permanent special committees, and working groups of the World Anti-Doping Agency.
``(ii) sporting organizations;
``(4) Voluntary nonpayment of dues.-- ``(A) In general.--In the case of a determination under paragraph (1) that the World Anti-Doping Agency has not met the criteria set forth in subparagraphs (A), (B), or (C) of that paragraph, the Office of National Drug Control Policy, in consultation with the appropriate committees of Congress, may voluntarily withhold up to the full amount of any funds made available for the payment of the United States membership dues to the World Anti-Doping Agency.
or ``(iii) athlete support personnel;
``(B) Return of funds after noncompliance.--Unless otherwise specified by law, any funds made available for the payment of the United States membership dues to the World Anti-Doping Agency that have been voluntarily withheld pursuant to subparagraph (A) and have not been obligated prior to the end of an applicable fiscal year shall be returned to the general fund of the Treasury.
and ``(D) work collaboratively with democratic countries.
``(5) Spending plan.--Not later than 30 days before the Office of National Drug Control Policy obligates funds to the World Anti-Doping Agency, the Office of National Drug Control Policy shall submit to the appropriate committees of Congress a spending plan and explanation of proposed uses of such funds.
``(2) Determination.-- ``(A) In general.--Not later than 90 days after the date of the enactment of this subsection, the Office of National Drug Control Policy, in consultation with the United States Anti-Doping Agency, the United States Olympic and Paralympic Committee, and the Team USA Athletes' Commission, shall make a determination as to whether the World Anti-Doping Agency-- ``(i) has a credible and independent governance model that provides for fair representation of the United States;
``(6) Appropriate committees of congress defined.--In this subsection, the term `appropriate committees of Congress' means-- ``(A) the Committee on Commerce, Science, and Transportation of the Senate;
``(ii) fully implements all governance reforms, including a proper conflict-of- interest policy described in paragraph (1)(A)(ii);
``(B) the Committee on Appropriations of the Senate;
and ``(iii) allows independent athletes from the United States and other democratic countries, or representatives of such athletes, to have decision-making roles on the Executive Committee and the Foundation Board, and in all relevant expert advisory groups, standing committees, permanent special committees, and working groups, of the World Anti-Doping Agency.
``(C) the Committee on Energy and Commerce of the House of Representatives;
``(B) Accountability.--In the case of a determination under subparagraph (A) that the World Anti-Doping Agency does not have such a governance model, has not fully implemented such governance reforms, or has not allowed decision-making roles described in clause (iii) of that subparagraph, the Office of National Drug Control Policy, in consultation with the United States Anti-Doping Agency, the United States Olympic and Paralympic Committee, and the Team USA Athletes' Commission, shall-- ``(i) use all available tools to ensure that the United States has fair representation in the World Anti-Doping Agency, including-- ``(I) on the Executive Committee;
and ``(D) the Committee on Appropriations of the House of Representatives.''.
``(II) on the Foundation Board;
Calendar No.
and ``(III) in all relevant expert advisory groups, standing committees, permanent special committees, and working groups of the World Anti-Doping Agency;
340 119th CONGRESS 2d Session S.
and ``(ii) not later than 180 days after the date on which the determination under subparagraph (A) is made, issue a report that describes the barriers to participation and fair representation of the United States on the Executive Committee, the Foundation Board, and all relevant expert advisory groups, standing committees, permanent special committees, and working groups of the World Anti-Doping Agency.
233 [Report No.
``(3) Voluntary nonpayment of dues.-- ``(A) In general.--In the case of a determination under paragraph (2)(A) that the World Anti-Doping Agency does not have a governance model that provides for fair representation of the United States, has not fully implemented governance reforms, or has not allowed decision-making roles described in clause (iii) of that subparagraph, the Office of National Drug Control Policy, in consultation with the appropriate committees of Congress, may voluntarily withhold up to the full amount of membership dues to the World Anti- Doping Agency.
119-111] _______________________________________________________________________ A BILL To amend the Office of National Drug Control Policy Reauthorization Act of 2006 to modify the authority of the Office of National Drug Control Policy with respect to the World Anti-Doping Agency, and for other purposes.
``(B) Appropriate committees of congress defined.-- In this paragraph, the term `appropriate committees of Congress' means-- ``(i) the Subcommittee on Consumer Protection, Product Safety, and Data Security of the Committee on Commerce, Science, and Transportation of the Senate (or a successor subcommittee);
_______________________________________________________________________ February 23, 2026 Reported with an amendment
``(ii) the Subcommittee on Financial Services and General Government of the Committee on Appropriations of the Senate (or a successor subcommittee);
``(iii) the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce of the House of Representatives (or a successor subcommittee);
and ``(iv) the Subcommittee on Financial Services and General Government of the Committee on Appropriations of the House of Representatives (or a successor subcommittee).
``(4) Spending plan.--Not later than 30 days before the Office of National Drug Control Policy obligates funds to the World Anti-Doping Agency, the Office of National Drug Control Policy shall submit to the Committee on Appropriations of the Senate and the Committee on Appropriations of the House of Representatives a spending plan and explanation of proposed uses of such funds.''.
<all>
⬇ Download PDF
View plain text versions (2)

What Congress says this changes

S. Rept. 119-111

Published by the reporting committee Not generated — this is the committee's own “Changes in Existing Law Made by the Bill, as Reported”.

Text to be removed appears in [brackets]. Newly inserted text is italicised in the official report and cannot be marked in this plain-text rendition — read the official PDF ↗ for the authoritative formatting. 

changes in existing law made by 
the bill, as reported, are shown as follows (existing law 
proposed to be omitted is enclosed in black brackets, new 
material is printed in italic, existing law in which no change 
is proposed is shown in roman):

 OFFICE OF NATIONAL DRUG CONTROL POLICY 
 REAUTHORIZATION ACT OF 2006

 * * * * * * *

 TITLE VII--ANTI-DOPING AGENCY

 [21 U.S.C. 2001; Public Law 117-103]

SEC. 701. DESIGNATION OF UNITED STATES ANTI-DOPING AGENCY.

 [(a) Definitions.--In this title:
 [(1) United states olympic committee.--The term 
 ``United States Olympic Committee'' means the 
 organization established by the ``Ted Stevens Olympic 
 and Amateur Sports Act'' (36 U.S.C. 220501 et seq.).
 [(2) Amateur athletic competition.--The term 
 ``amateur athletic competition'' means a contest, game, 
 meet, match, tournament, regatta, or other event in 
 which amateur athletes compete (36 U.S.C. 
 220501(b)(2)).
 [(3) Amateur athlete.--The term ``amateur athlete'' 
 means an athlete who meets the eligibility standards 
 established by the national governing body or 
 paralympic sports organization for the sport in which 
 the athlete competes (36 U.S.C. 22501(b)(1)).]
 (a) Definitions.--In this subchapter:
 (1) Amateur athlete.--The term ``amateur athlete'' 
 has the meaning given that term in section 220501(b)(1) 
 of title 36, United States Code.
 (2) Amateur athletic competition.--The term ``amateur 
 athletic competition'' has the meaning given that term 
 in section 220501(b)(2) of title 36, United States 
 Code.
 (3) Independent athlete.--The term ``independent 
 athlete'' means a current or former amateur athlete who 
 does not serve, in any capacity--
 (A) on the International Olympic Committee;
 (B) on the International Paralympic 
 Committee;
 (C) at an international sports federation 
 recognized by the International Olympic 
 Committee or the International Paralympic 
 Committee;
 (D) on the United States Olympic and 
 Paralympic Committee;
 (E) at a national governing body (as defined 
 in section 220501(b)(9) of title 36, United 
 States Code); or
 (F) at the World Anti-Doping Agency.
 (4) United states olympic and paralympic committee.--
 The term ``United States Olympic and Paralympic 
 Committee'' means the organization established by 
 chapter 2205 of title 36, United States Code.
 (b) In General.--The United States Anti-Doping Agency shall--
 (1)(A) serve as the independent anti-doping 
 organization for the amateur athletic competitions 
 recognized by the United States Olympic and Paralympic 
 Committee;
 (B) be responsible for certifying in advance any 
 testing conducted by international organizations under 
 the World Anti-Doping Code for international amateur 
 athletes and athletic competitions occurring within the 
 jurisdiction of the United States; and
 (C) be recognized worldwide as the independent 
 national anti-doping organization for the United 
 States;
 (2) ensure that athletes participating in amateur 
 athletic activities recognized by the [United States 
 Olympic Committee] United States Olympic and Paralympic 
 Committee are prevented from using performance-
 enhancing drugs or prohibited performance-enhancing 
 methods adopted by the Agency;
 (3) implement anti-doping education, research, 
 testing, and adjudication programs to prevent United 
 States Amateur Athletes participating in any activity 
 recognized by the [United States Olympic Committee] 
 United States Olympic and Paralympic Committee from 
 using performance-enhancing drugs or prohibited 
 performance-enhancing methods adopted by the Agency;
 (4) serve as the United States representative 
 responsible for coordination with other anti-doping 
 organizations coordinating amateur athletic 
 competitions recognized by the [United States Olympic 
 Committee] United States Olympic and Paralympic 
 Committee to ensure the integrity of athletic 
 competition, the health of the athletes, and the 
 prevention of use by United States amateur athletes of 
 performance-enhancing drugs or prohibited performance-
 enhancing methods adopted by the Agency; and
 (5) promote a positive youth sport experience by 
 using a portion of the funding of the United States 
 Anti-Doping Agency to provide educational materials on 
 sportsmanship, character building, and healthy 
 performance for the athletes, parents, and coaches who 
 participate in youth sports.
 (c) Due Process in Arbitration Proceedings.--Any action taken 
by the United States Anti-Doping Agency to enforce a policy, 
procedure, or requirement of the United States Anti-Doping 
Agency against a person with respect to a violation of Federal 
law, including an investigation, a disciplinary action, a 
sanction, or any other administrative action, shall be carried 
out in a manner that provides due process protection to the 
person.
 (d) Authority With Respect to the World Anti-Doping Agency.--
 (1) Annual determination.--Not later than 180 days 
 after the date of the enactment of this subsection, and 
 annually thereafter, the Office of National Drug 
 Control Policy, in consultation with the United States 
 Anti-Doping Agency, the United States Olympic and 
 Paralympic Committee, and the Athletes' Advisory 
 Council (established and maintained under section 
 220504(b)(2)(A) of title 36, United States Code) shall 
 make a determination as to whether the World Anti-
 Doping Agency--
 (A) has a credible and independent governance 
 model that provides for fair representation of 
 the United States;
 (B) fully implements or has implemented 
 governance reforms to ensure independent 
 governance; and
 (C) has fair processes and procedures to 
 select independent athletes, including athletes 
 from the United States and other democratic 
 countries, or representatives of such athletes, 
 for decision-making roles on the Executive 
 Committee and the Foundation Board, and in all 
 relevant expert advisory groups, standing 
 committees, permanent special committees, and 
 working groups of the World Anti-Doping Agency.
 (2) Accountability.--In the case of a determination 
 under paragraph (1) that the World Anti-Doping Agency 
 has not met the criteria set forth in subparagraphs 
 (A), (B), or (C) of that paragraph, the Office of 
 National Drug Control Policy, in consultation with the 
 United States Anti-Doping Agency, the United States 
 Olympic and Paralympic Committee, and the Athletes' 
 Advisory Council (established and maintained under 
 section 220504(b)(2)(A) of title 36, United States 
 Code), shall use all available tools and best efforts 
 to bring the World Anti-Doping Agency into compliance 
 with the criteria set forth in that paragraph.
 (3) Report.--In the case of a determination under 
 paragraph (1) that the World Anti-Doping Agency has not 
 met the criteria set forth in subparagraphs (A), (B), 
 or (C) of that paragraph, not later than 180 days after 
 the date on which that determination is made, the 
 Office of National Drug Control Policy, in consultation 
 with the United States Anti-Doping Agency, the United 
 States Olympic and Paralympic Committee, and the 
 Athletes' Advisory Council (established and maintained 
 under section 220504(b)(2)(A) of title 36, United 
 States Code) shall submit to the appropriate committees 
 of Congress a report that describes the barriers to 
 participation and fair representation of the United 
 States on the Executive Committee, the Foundation 
 Board, and all relevant expert advisory groups, 
 standing committees, permanent special committees, and 
 working groups of the World Anti-Doping Agency.
 (4) Voluntary nonpayment of dues.--
 (A) In general.--In the case of a 
 determination under paragraph (1) that the 
 World Anti-Doping Agency has not met the 
 criteria set forth in subparagraphs (A), (B), 
 or (C) of that paragraph, the Office of 
 National Drug Control Policy, in consultation 
 with the appropriate committees of Congress, 
 may voluntarily withhold up to the full amount 
 of any funds made available for the payment of 
 the United States membership dues to the World 
 Anti-Doping Agency.
 (B) Return of funds after noncompliance.--
 Unless otherwise specified by law, any funds 
 made available for the payment of the United 
 States membership dues to the World Anti-Doping 
 Agency that have been voluntarily withheld 
 pursuant to subparagraph (A) and have not been 
 obligated prior to the end of an applicable 
 fiscal year shall be returned to the general 
 fund of the Treasury.
 (5) Spending plan.--Not later than 30 days before the 
 Office of National Drug Control Policy obligates funds 
 to the World Anti-Doping Agency, the Office of National 
 Drug Control Policy shall submit to the appropriate 
 committees of Congress a spending plan and explanation 
 of proposed uses of such funds.
 (6) Appropriate committees of congress defined.--In 
 this subsection, the term `appropriate committees of 
 Congress' means--
 (A) the Committee on Commerce, Science, and 
 Transportation of the Senate;
 (B) the Committee on Appropriations of the 
 Senate;
 (C) the Committee on Energy and Commerce of 
 the House of Representatives; and
 (D) the Committee on Appropriations of the 
 House of Representatives.

 * * * * * * *

Source: S. Rept. 119-111 · govinfo

Action History

  1. Introduced in Senate

  2. Read twice and referred to the Committee on Commerce, Science, and Transportation.

  3. Committee on Commerce, Science, and Transportation. Ordered to be reported with an amendment in the nature of a substitute favorably.

  4. Committee on Commerce, Science, and Transportation. Reported by Senator Cruz with an amendment in the nature of a substitute. With written report No. 119-111.

  5. Committee on Commerce, Science, and Transportation. Reported by Senator Cruz with an amendment in the nature of a substitute. With written report No. 119-111.

  6. Placed on Senate Legislative Calendar under General Orders. Calendar No. 340.

Sponsors

Sponsorship breakdown

Export CSV (upgrade) →

1 sponsors · 6 co-sponsors · 540 not signed on

Sponsors (1)

Co-sponsors (6)

Not signed on (540)

540 members have not signed on to this bill.

Show all 540 →

"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.

Whip count is in markup. Polling the chamber and every recorded vote this session. Only the first open is slow. It’s instant for you after this. Calling the roll · Tallying · Engrossing

Subjects

public-safety civil-rights
Cross-referencing the record. Reading this bill against every other bill in the corpus by meaning, not keywords. Only the first open is slow. It’s instant for you after this. Matching · Ranking · Engrossing

Frequently asked questions

What does S 233 do?
Restoring Confidence in the World Anti-Doping Agency Act of 2025This bill requires the Office of National Drug Control Policy (ONDCP) to annually evaluate the governance and procedures of the World Anti-Doping Agency (WADA).Specifically, the ONDCP, in consultation with the United States Anti-Doping Agency, the United States Olympic and Paralympic Committee, the Athletes' Advisory Council (Team USA AC), must determine whether WADAhas a credible and independent governance model that provides for fair representation of the United States; fully implements or has implemented governance reforms to ensure independent governance; andhas fair processes and procedures for selecting independent athletes for decision-making roles on the WADA Executive Committee, the WADA Foundation Board, and relevant expert advisory groups, standing committees, permanent special committees, and working groups of WADA.If the ONDCP determines WADA has not met these criteria, the ONDCP must use all available tools and efforts to bring WADA into compliance with them.Further, upon such a determination, the ONDCP may withhold up to the full amount of the United States' membership dues to WADA.
Who sponsors S 233?
S 233 is sponsored by Blackburn, Marsha (Republican), Van Hollen, Chris (Democratic), Capito, Shelley Moore (Republican), Blumenthal, Richard (Democratic), Wicker, Roger F. (Republican), Blunt Rochester, Lisa (Democratic), and Luján, Ben Ray (Democratic).
What is the current status of S 233?
This bill is in committee in the Senate. Introduced January 23, 2025. It must pass committee before a floor vote.
Where can I track S 233?
Track S 233 free on One Click Politics — get push/email alerts when it moves.

Make your voice heard on S 233

Find the representatives who decide this bill and tell them where you stand — for yourself, or mobilize your whole list in one click with One Click Politics advocacy software.

Find my representatives → Run a campaign

Stay ahead of S 233

Last checked for changes 3 months ago · updated continuously

One Click Politics tracks every bill in Congress and all 50 states.

Track this bill →